Development, optimization, and biovalidation of 99mTc–insulin complex

[1]  M. Sohaib,et al.  Synthesis, characterization and biological evaluation of 99mTc-labeled Mitomycin C , 2014, Journal of Radioanalytical and Nuclear Chemistry.

[2]  M. Sohaib,et al.  Labelling of ceftriaxone with (99m) Tc and its bio-evaluation as an infection imaging agent. , 2014, Journal of labelled compounds & radiopharmaceuticals.

[3]  M. Rajoka,et al.  Preparation, Biodistribution, and Scintigraphic Evaluation of 99mTc-Clindamycin: an Infection Imaging Agent , 2014, Applied Biochemistry and Biotechnology.

[4]  M. Sanad.  Novel radiochemical and biological characterization of 99mTc-histamine as a model for brain imaging , 2014, Journal of Analytical Science and Technology.

[5]  I. Y. Abdel-Ghaney,et al.  Synthesis of 99mTc-erythromycin complex as a model for infection sites imaging , 2013, Radiochemistry.

[6]  M. Sanad,et al.  Labeling of ursodeoxycholic acid with technetium-99m for hepatobiliary imaging , 2013, Journal of Radioanalytical and Nuclear Chemistry.

[7]  H. Barrett,et al.  Imaging of rat cerebral ischemia-reperfusion injury using(99m)Tc-labeled duramycin. , 2013, Nuclear medicine and biology.

[8]  M. Sohaib,et al.  (99m)Tc-daunorubicin a potential brain imaging and theranostic agent: synthesis, quality control, characterization, biodistribution and scintigraphy. , 2013, Nuclear medicine and biology.

[9]  Ahmad Jahed Mushtaq,et al.  Direct labeling of doxorubicin with technetium-99m: its optimization, characterization and quality control , 2012, Journal of Radioanalytical and Nuclear Chemistry.

[10]  A. El-Bayoumy,et al.  Optimization of the reaction conditions for the preparation of 99mTc-celecoxib and its biological evaluation , 2011 .

[11]  T. Yen,et al.  Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. , 2010, Biomaterials.

[12]  I. T. Ibrahim,et al.  Synthesis and biological distribution of 99mTc–norfloxacin complex, a novel agent for detecting sites of infection , 2010 .

[13]  M. A. Motaleb.  Radiochemical and biological characteristics of 99mTc‐difloxacin and 99mTc‐pefloxacin for detecting sites of infection , 2010 .

[14]  J. DeVries,et al.  Insulin Therapy for Type 2 Diabetes , 2009, Diabetes Care.

[15]  M. Aşıkoğlu,et al.  The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[16]  S. Pervez,et al.  Formulation of a freeze-dried kit for the preparation of 99mTc-tetrofosmin , 2009 .

[17]  Bernhard Scholten,et al.  Radiochimica Acta , 2009 .

[18]  R. Misra,et al.  Biomaterials , 2008 .

[19]  M. A. Motaleb.  Preparation of 99mTc-cefoperazone complex, a novel agent for detecting sites of infection , 2007 .

[20]  Boli Liu,et al.  Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor. , 2006, Bioorganic & medicinal chemistry letters.

[21]  Ahmad Jahed Mushtaq,et al.  Synthesis, quality control and biodistribution of 99mTc-Kanamycin , 2006 .

[22]  S. Malik,et al.  Synthesis and biodistribution of 99mTc-Vancomycin in a model of bacterial infection , 2005 .

[23]  P. Halban,et al.  High-performance liquid chromatography (HPLC): A rapid, flexible and sensitive method for separating islet proinsulin and insulin , 1986, Diabetologia.

[24]  G. Guiochon,et al.  Modeling of Preparative Reversed‐Phase HPLC of Insulin , 2002, Biotechnology progress.

[25]  P. Sőnksen,et al.  Insulin: understanding its action in health and disease. , 2000, British journal of anaesthesia.

[26]  Warszawski Uniwersytet Medyczny,et al.  Diabetes care , 2019, Health at a Glance.

[27]  L. Yaffe.  Radiochemistry. , 2020, Nucleonics.